Survival outcomes in patients with chemotherapy-naive metastatic castration-resistant prostate cancer treated with enzalutamide or abiraterone acetate

被引：0
|
作者：
Scott T. Tagawa
Krishnan Ramaswamy
Ahong Huang
Jack Mardekian
Neil M. Schultz
Li Wang
Rickard Sandin
Stanislav Lechpammer
Daniel J. George
机构：
[1] Weill Cornell Medicine,
[2] Pfizer Inc.,undefined
[3] STATinMED Research,undefined
[4] Astellas Pharma Inc.,undefined
[5] Pfizer AB.,undefined
[6] Pfizer Inc.,undefined
[7] Duke Cancer Institute,undefined
[8] Duke University School of Medicine,undefined
来源：
Prostate Cancer and Prostatic Diseases | 2021年 / 24卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1032 / 1040
页数：8
相关论文
共 50 条
  • [31] Abiraterone or Enzalutamide for Patients With Metastatic Castration-Resistant Prostate Cancer
    La, Jennifer
    Wang, Lin
    Corrigan, June K.
    Lang, Deborah
    Lee, Michelle H.
    Do, Nhan V.
    Brophy, Mary T.
    Paller, Channing J.
    Fillmore, Nathanael R.
    JAMA NETWORK OPEN, 2024, 7 (08)
  • [32] Enzalutamide in Combination with Abiraterone Acetate in Bone Metastatic Castration-resistant Prostate Cancer Patients
    Efstathiou, Eleni
    Titus, Mark
    Wen, Sijin
    Troncoso, Patricia
    Hoang, Anh
    Corn, Paul
    Prokhorova, Ina
    Araujo, John
    Dmuchowski, Carl
    Melhem-Bertrandt, Amal
    Patil, Shiva
    Logothetis, Christopher J.
    EUROPEAN UROLOGY ONCOLOGY, 2020, 3 (01): : 119 - 127
  • [33] Prognostic Index Model for Progression-Free Survival in Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone Acetate Plus Prednisone
    Ryan, Charles J.
    Kheoh, Thian
    Li, Jinhui
    Molina, Arturo
    De Porre, Peter
    Carles, Joan
    Efstathiou, Eleni
    Kantoff, Philip W.
    Mulders, Peter F. A.
    Saad, Fred
    Chi, Kim N.
    CLINICAL GENITOURINARY CANCER, 2018, 16 (01) : 72 - +
  • [34] Enzalutamide in Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer: An Asian Multiregional, Randomized Study
    Pu, Yeong-Shiau
    Ahn, Hanjong
    Han, Weiqing
    Huang, Shu-Pin
    Wu, Hsi-Chin
    Ma, Lulin
    Yamada, Shunsuke
    Suga, Kazutaka
    Xie, Li-Ping
    ADVANCES IN THERAPY, 2022, 39 (06) : 2641 - 2656
  • [35] Economic Outcomes in Patients with Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide or Abiraterone Acetate Plus Prednisone
    Krishnan Ramaswamy
    Stanislav Lechpammer
    Jack Mardekian
    Ahong Huang
    Neil M. Schultz
    Rickard Sandin
    Li Wang
    Onur Baser
    Daniel J. George
    Advances in Therapy, 2020, 37 : 2083 - 2097
  • [36] Phase-1 study of abiraterone acetate in chemotherapy-naive Japanese patients with castration-resistant prostate cancer
    Matsubara, Nobuaki
    Uemura, Hiroji
    Fukui, Iwao
    Niwakawa, Masashi
    Yamaguchi, Akito
    Iizuka, Koho
    Akaza, Hideyuki
    CANCER SCIENCE, 2014, 105 (10) : 1313 - 1320
  • [37] Development and validation of a survival nomogram and calculator for male patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate and/or enzalutamide
    Takashi Kawahara
    Yusuke Saigusa
    Shuko Yoneyama
    Masashi Kato
    Ippei Kojima
    Hiroshi Yamada
    Osamu Kamihira
    Kenichi Tabata
    Hideyasu Tsumura
    Masatsugu Iwamura
    Kazuhide Makiyama
    Hiroji Uemura
    Yasuhide Miyoshi
    BMC Cancer, 23
  • [38] Development and validation of a survival nomogram and calculator for male patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate and/or enzalutamide
    Kawahara, Takashi
    Saigusa, Yusuke
    Yoneyama, Shuko
    Kato, Masashi
    Kojima, Ippei
    Yamada, Hiroshi
    Kamihira, Osamu
    Tabata, Kenichi
    Tsumura, Hideyasu
    Iwamura, Masatsugu
    Makiyama, Kazuhide
    Uemura, Hiroji
    Miyoshi, Yasuhide
    BMC CANCER, 2023, 23 (01)
  • [39] Healthcare Costs for Metastatic Castration-Resistant Prostate Cancer Patients Treated with Abiraterone or Enzalutamide
    Rana, Dikshyanta
    Geue, Claudia
    Baillie, Kelly
    Pan, Jiafeng
    Mueller, Tanja
    Laskey, Jennifer
    Bennie, Marion
    Clarke, Julie
    Jones, Robert J.
    Brown, Ailsa
    Wu, Olivia
    PHARMACOECONOMICS-OPEN, 2022, 6 (02) : 303 - 313
  • [40] COST-EFFECTIVENESS ANALYSIS OF ENZALUTAMIDE FOR PATIENTS WITH CHEMOTHERAPY-NAIVE METASTATIC CASTRATION-RESISTANT PROSTATE CANCER IN JAPAN
    Okumura, H.
    Inoue, S.
    Naidoo, S.
    Holmstrom, S.
    Akaza, H.
    VALUE IN HEALTH, 2017, 20 (05) : A107 - A107
12345